These data suggest not only that conventional biomarkers would support an incorrect conclusion in this setting, but also indicate that the tumors in cluster 3 may be potentially dictated by other tumor-promoting cascades than AR, such as FGF, WNT, and NGF pathways. The gene discussed is NGF; the disease is neoplasm.